BioLife Solutions (BLFS) Misses Q4 EPS by 20c

BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.

GUIDANCE:

BioLife Solutions sees FY2022 revenue of $159.5-171 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15